RKDA - Arcadia Biosciences, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 519.63M
Enterprise Value 3-590.23k
Trailing P/E N/A
Forward P/E 1-1.23
PEG Ratio (5 yr expected) 1-0.05
Price/Sales (ttm)13.94
Price/Book (mrq)23.73
Enterprise Value/Revenue 3-0.42
Enterprise Value/EBITDA 60.03

Trading Information

Stock Price History

Beta (3Y Monthly) -2.44
52-Week Change 3-57.16%
S&P500 52-Week Change 37.70%
52 Week High 310.4000
52 Week Low 32.6450
50-Day Moving Average 33.9767
200-Day Moving Average 35.0820

Share Statistics

Avg Vol (3 month) 3115.68k
Avg Vol (10 day) 389.52k
Shares Outstanding 54.78M
Float 3.56M
% Held by Insiders 133.31%
% Held by Institutions 15.92%
Shares Short (Jun 28, 2019) 456.26k
Short Ratio (Jun 28, 2019) 40.32
Short % of Float (Jun 28, 2019) 41.55%
Short % of Shares Outstanding (Jun 28, 2019) 40.90%
Shares Short (prior month May 31, 2019) 4140.07k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3Jan 24, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,225.07%

Management Effectiveness

Return on Assets (ttm)-48.40%
Return on Equity (ttm)-2,381.08%

Income Statement

Revenue (ttm)1.41M
Revenue Per Share (ttm)0.32
Quarterly Revenue Growth (yoy)-26.20%
Gross Profit (ttm)-5.27M
EBITDA -17.11M
Net Income Avi to Common (ttm)-15.48M
Diluted EPS (ttm)-3.5060
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.79M
Total Cash Per Share (mrq)3.72
Total Debt (mrq)2.35M
Total Debt/Equity (mrq)370.46
Current Ratio (mrq)6.26
Book Value Per Share (mrq)0.13

Cash Flow Statement

Operating Cash Flow (ttm)-14.98M
Levered Free Cash Flow (ttm)-9.68M